ReviewFrontiers in pharmacology2023

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis.

Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.